Work

Abstract 2953: CS5006: A novel integrin β4-targeted antibody-drug conjugate (ADC) with robust antitumor activity in preclinical studies

Year: 2025
Type: conference-abstract
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4409689846
Cites:
Cited by:
Related to: 10